On Monday, the Food and Drug Administration posted documents outlining concerns about a lack of evidence for the batch of peptides set to be considered by an FDA panel in about three weeks
The strength of clinical recommendations based on the SORT framework is provided in Table 2
Thus, individuals with food-bound vitamin B 12 malabsorption do not have an increased requirement for vitamin B 12
We screen for this at consultation
et al., Altern Ther Health Med (2024) Pilot study on BPC-157 for interstitial cystitis (private clinic) Orthopaedic & Wellness (2023) Peptide Dangers blog highlighting conflicts of interest and unknown risks USADA Spirit of Sport blog (2020): Warning to athletes about BPC-157s unapproved status usada.org
Ultimately, the right choice depends on your urgency, budget, and whether you meet the strict criteria for NHS treatment